Adoption of Telemedicine Cuts Greenhouse Gas Emissions
By Lori Solomon HealthDay Reporter
THURSDAY, May 1, 2025 -- Telemedicine use modestly decreases the carbon footprint of U.S. health care delivery, according to a study published online April 22 in the American Journal of Managed Care.
Benjo Delarmente, M.D., Ph.D., from the University of California, Los Angeles, and colleagues used multipayer claims data to estimate carbon dioxide (CO2) emissions averted from the avoidance of travel by using telemedicine as a substitute for the usual source of in-person care between April 1, 2023, and June 30, 2023.
The researchers found that during the study period, there was a monthly average of 1,481,530 telemedicine visits (65,733 rural). An estimated 740,765 to 1,348,192 of these telemedicine visits were substitutes for in-person visits. When accounting for 2021 electric vehicle (EV) production share and emissions per mile, an estimated 4,075,065 and 7,489,486 kg of CO2 were averted due to telemedicine use each month. When accounting for EV and public transportation use, 4 to 8.9 million kg of CO2 were averted per month. When extrapolating to the entire U.S. adult population, an estimated 21.4 to 47.6 million kg of CO2 in monthly emissions were averted, which is roughly equivalent to the monthly emissions of 61,255 to 130,076 gasoline-powered passenger vehicles.
"Policy makers and payers should recognize the positive environmental impact of telemedicine utilization when considering future policies that might impact access to, and reimbursement of, telemedicine," the authors write.
Several authors disclosed ties to relevant organizations.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2025-05-02 06:00
Read more

- Hearing Loss Could Predict Heart Failure
- Unnecessary Imaging Scans Contributing To Climate Change
- Alternative To Hip Replacement Helps Patients Remain Physically Active
- AAN: Tolebrutinib Slows Disability in Nonrelapsing Secondary Progressive MS
- Scooter Riders Were High Or Drunk In A Quarter Of Wrecks
- Experts Warn Bird Flu Could Pose Growing Risk to Human Health
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions